Reuters | ELN Message Board Posts


ELN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  414941 of 548890  at  5/12/2010 1:49:05 PM  by

callejerro1


Reuters

The Reuters article stated: "the team found that bapineuzumab shrank brain plaques by 25 percent, but Gandy said the drug had no effect on patients' ability to think and reason"...which means they were stabilized ?...which I would assume would be a huge success since it could be damage not reversible in short order (years for nerve regeneration)....which makes bap taking out the oligomers early on in the process as the most effective process but can still stabilize an Alz patient !!!...granted the oligomers and not the plaques may be the precursors so eliminate before they become plaques...as well isn't the TTHI collaboration on a compound that eliminates the oligomers prior to plaque formation as well ?


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 23  
   Views: 658 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
414949 Re: Reuters elnanonymous 3 5/12/2010 2:12:10 PM
414969 Re: Reuters rosemountbomber 2 5/12/2010 3:45:00 PM


Financial Market Data provided by
.
Loading...